Growth Metrics

Pfizer (PFE) Assets (2016 - 2026)

Pfizer has reported Assets over the past 18 years, most recently at $208.0 billion for Q1 2026.

  • Quarterly Assets changed 0.01% to $208.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $208.0 billion through Mar 2026, changed 0.01% year-over-year, with the annual reading at $208.2 billion for FY2025, 2.45% down from the prior year.
  • Assets was $208.0 billion for Q1 2026 at Pfizer, roughly flat from $208.2 billion in the prior quarter.
  • Over five years, Assets peaked at $226.5 billion in Q4 2023 and troughed at $41.1 billion in Q4 2022.
  • The 5-year median for Assets is $208.2 billion (2025), against an average of $199.1 billion.
  • Year-over-year, Assets fell 11.22% in 2022 and then surged 422.64% in 2023.
  • A 5-year view of Assets shows it stood at $197.0 billion in 2022, then grew by 14.98% to $226.5 billion in 2023, then decreased by 5.79% to $213.4 billion in 2024, then dropped by 2.45% to $208.2 billion in 2025, then fell by 0.08% to $208.0 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Assets are $208.0 billion (Q1 2026), $208.2 billion (Q4 2025), and $209.0 billion (Q3 2025).